Purpose: The present study aims to evaluate a set of oxidative stress biomarkers in the amniotic fluid (AF) of women carrying Down syndrome (DS) fetuses that could prove in vivo the early occurrence of oxidative damage in DS. Experimental design: To assess the extent of protein oxidation in DS AF, we measured protein carbonylation and protein-bound HNE by slot-blot analysis, total and oxidized GSH levels by enzymatic assay and heat shock proteins (HSPs) thioredoxin (Trx) induction by Western blot. Further, by a redox proteomics approach specific targets of protein carbonylation were identified. Results: We found increased levels of oxidative stress, as indexed by increased protein oxidation, lipid peroxidation, reduction of GSH and Trx levels and induction of the HSP response. By a redox proteomics approach, we identified selective proteins which showed increased oxidation in DS fetuses compared with healthy controls. The identified proteins are involved in iron homeostasis (ceruloplasmin and transferin), lipid metabolism (zinc-alpha 2-glycoprotein, retinol-binding protein 4 and apolipoprotein A1) and inflammation (complement C9, alpha-1B-glycoprotein, collagen alpha-1V chain) with critical relevance in the clinical outcome of DS. Conclusions and clinical relevance: Our results indicate that oxidative damage is an early event in the DS pathogenesis and might contribute to the development of deleterious DS phenotypes, including abnormal development and AD-like neuropathology.

Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid / Perluigi, Marzia; DI DOMENICO, Fabio; Fiorini, Ada; Cocciolo, Annalisa; Giorgi, Alessandra; Cesira, Foppoli; D., Allan Butterfield; Maurizio, Giorlandino; Claudio, Giorlandino; Schinina', Maria Eugenia; Coccia, Raffaella. - In: PROTEOMICS. CLINICAL APPLICATIONS. - ISSN 1862-8346. - 5:3-4(2011), pp. 167-178. [10.1002/prca.201000121]

Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid

PERLUIGI, Marzia;DI DOMENICO, FABIO;FIORINI, ADA;COCCIOLO, Annalisa;GIORGI, ALESSANDRA;SCHININA', Maria Eugenia;COCCIA, Raffaella
2011

Abstract

Purpose: The present study aims to evaluate a set of oxidative stress biomarkers in the amniotic fluid (AF) of women carrying Down syndrome (DS) fetuses that could prove in vivo the early occurrence of oxidative damage in DS. Experimental design: To assess the extent of protein oxidation in DS AF, we measured protein carbonylation and protein-bound HNE by slot-blot analysis, total and oxidized GSH levels by enzymatic assay and heat shock proteins (HSPs) thioredoxin (Trx) induction by Western blot. Further, by a redox proteomics approach specific targets of protein carbonylation were identified. Results: We found increased levels of oxidative stress, as indexed by increased protein oxidation, lipid peroxidation, reduction of GSH and Trx levels and induction of the HSP response. By a redox proteomics approach, we identified selective proteins which showed increased oxidation in DS fetuses compared with healthy controls. The identified proteins are involved in iron homeostasis (ceruloplasmin and transferin), lipid metabolism (zinc-alpha 2-glycoprotein, retinol-binding protein 4 and apolipoprotein A1) and inflammation (complement C9, alpha-1B-glycoprotein, collagen alpha-1V chain) with critical relevance in the clinical outcome of DS. Conclusions and clinical relevance: Our results indicate that oxidative damage is an early event in the DS pathogenesis and might contribute to the development of deleterious DS phenotypes, including abnormal development and AD-like neuropathology.
2011
amniotic fluid; down syndrome; oxidative stress; protein oxidation; redox proteomics
01 Pubblicazione su rivista::01a Articolo in rivista
Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid / Perluigi, Marzia; DI DOMENICO, Fabio; Fiorini, Ada; Cocciolo, Annalisa; Giorgi, Alessandra; Cesira, Foppoli; D., Allan Butterfield; Maurizio, Giorlandino; Claudio, Giorlandino; Schinina', Maria Eugenia; Coccia, Raffaella. - In: PROTEOMICS. CLINICAL APPLICATIONS. - ISSN 1862-8346. - 5:3-4(2011), pp. 167-178. [10.1002/prca.201000121]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/354279
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 45
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 86
social impact